JT, J., H, W., J, A., L, A., D, O., & J, M. (2021). A Companion Diagnostic With Significant Clinical Impact in Treatment of Breast and Gastric Cancer. Frontiers in oncology, 11, 676939. https://doi.org/10.3389/fonc.2021.676939
Chicago Style (17th ed.) CitationJT, Jørgensen, Winther H, Askaa J, Andresen L, Olsen D, and Mollerup J. "A Companion Diagnostic With Significant Clinical Impact in Treatment of Breast and Gastric Cancer." Frontiers in Oncology 11 (2021): 676939. https://doi.org/10.3389/fonc.2021.676939.
MLA (9th ed.) CitationJT, Jørgensen, et al. "A Companion Diagnostic With Significant Clinical Impact in Treatment of Breast and Gastric Cancer." Frontiers in Oncology, vol. 11, 2021, p. 676939, https://doi.org/10.3389/fonc.2021.676939.